SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Ipca Laboratories - Quaterly Results

13 Nov 2021 Evaluate
The Revenue for the quarter ended  September 2021 of Rs. 14238.40 millions grew by 9.71 % from Rs. 12977.70 millions.Net profit declined -6.54% to Rs. 2576.40 millions from Rs. 2756.80 millions.The Operating Profit of the company witnessed a decrease to 3740.90 millions from 3751.60 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202109 202009 % Var 202109 202009 % Var 202103 202003 % Var
Sales 14238.40 12977.70 9.71 29024.40 27830.20 4.29 51391.60 43674.30 17.67
Other Income 150.70 150.00 0.47 286.80 266.80 7.50 622.40 646.90 -3.79
PBIDT 3740.90 3751.60 -0.29 7816.80 9747.90 -19.81 15758.20 9794.50 60.89
Interest 14.70 18.10 -18.78 27.30 42.70 -36.07 81.40 157.90 -48.45
PBDT 3726.20 3733.50 -0.20 7789.50 9705.20 -19.74 15676.80 9636.60 62.68
Depreciation 505.00 462.60 9.17 1004.60 914.90 9.80 1877.20 1786.90 5.05
PBT 3221.20 3270.90 -1.52 6784.90 8790.30 -22.81 13799.60 7849.70 75.80
TAX 644.80 514.10 25.42 1361.30 1497.10 -9.07 2391.90 1325.10 80.51
Deferred Tax 83.00 -6.90 -1302.90 174.50 -38.90 -548.59 -57.90 -54.70 5.85
PAT 2576.40 2756.80 -6.54 5423.60 7293.20 -25.63 11407.70 6524.60 74.84
Equity 253.70 253.70 0.00 253.70 253.70 0.00 253.70 252.70 0.40
PBIDTM(%) 26.27 28.91 -9.11 26.93 35.03 -23.11 30.66 22.43 36.73

Ipca Laboratories Share Price

1551.75 -6.15 (-0.39%)
08-May-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1847.30
Dr. Reddys Lab 1293.25
Cipla 1347.70
Zydus Lifesciences 938.90
Lupin 2377.90
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×